Table 3 |
||
|
Cytogenetic findings in patients with myeloid sarcoma |
||
|
Case |
Cytogenetics |
Pathologic diagnosis |
|
|
||
|
1 |
46, XY |
Monoblastic sarcoma* |
|
2 |
47, XY, +21 |
Myelomonocytic sarcoma |
|
3 |
46, XY, del(8)(q24.2) |
DGS*** |
|
4 |
N/A |
DGS*** |
|
5 |
46, XX |
Monoblastic sarcoma* |
|
6 |
46, XY |
Monoblastic sarcoma* |
|
7 |
46, XX |
Monoblastic sarcoma* |
|
8 |
N/A |
Myelomonocytic sarcoma |
|
9 |
46, XX |
IGS** |
|
10 |
47, XY, +8, t(9;22)(q34;q11.2) |
DGS*** |
|
11 |
48, XX, +8, +13 |
Monocytic sarcoma |
|
12 |
47, XX, t(4;7)(p12;p11.2), Inv(9)(p12q13), inv(16)(p13.1q22) |
IGS** |
|
13 |
46, XX, inv (16)(p13.1q22) |
Myelomonocytic sarcoma |
|
|
||
|
* MS de novo ** IGS: Immature granulocytic sarcoma ***DGS: Differentiated granulocytic sarcoma |
||
|
Alexiev et al. Diagnostic Pathology 2007 2:42 doi:10.1186/1746-1596-2-42 |
||